Recombinant Forms of HIV-1 in the Last Decade of the Epidemic in the Russian Federation

Author:

Antonova Anastasiia1ORCID,Kazennova Elena1,Lebedev Aleksey1ORCID,Ozhmegova Ekaterina1ORCID,Kuznetsova Anna1ORCID,Tumanov Aleksandr1,Bobkova Marina2ORCID

Affiliation:

1. The National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia

2. I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia

Abstract

Currently, HIV-1 displays a substantial level of genetic diversity on a global scale, partly attributed to its recombinant variants. This study seeks to identify and analyze HIV-1 recombinants in Russia during the last decade of the epidemic. A comprehensive examination was conducted, encompassing 3178 partial pol sequences. Subtyping was achieved through various programs including COMET, the Stanford Database, REGA, jpHMM, RIP, and RDP4 for recombination analysis. The study also involved phylogenetic analysis to trace the origins of the identified recombinants. Primary resistance (PrimDR) prevalence and Drug Resistance Mutations (DRMs) were assessed. The study uncovered an overall proportion of recombinants at 8.7%, with a statistically significant increase in their frequency observed over time (p < 0.001). The Northwestern (18.5%) and Siberian (15.0%) Federal Districts exhibited a high prevalence of recombinants, while the Volga (1.9%) and Ural (2.8%) Federal Districts had a lower prevalence. Among HIV-1 recombinants, a PrimDR prevalence of 11.4% was identified. Notably, significant differences in DRMs were observed, with a higher prevalence of M184V in sub-subtype A6 (p = 0.018) and K103N in CRF63_02A6 (p = 0.002). These findings underscore the increasing HIV-1 genetic diversity and highlight a substantial prevalence of PrimDR among its recombinant forms, emphasizing the necessity for ongoing systematic monitoring.

Funder

Russian Science Foundation

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference58 articles.

1. World Health Organization (2023, September 01). HIV and AIDS. Key Facts, Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.

2. Pokrovsky, V.V., Ladnaya, N.N., and Sokolov, E.V. (2023, September 01). HIV Infection. Newsletter No. 47. Available online: http://www.hivrussia.info/wp-content/uploads/2023/05/Byulleten-47-VICH-infektsiya-za-2021-g.pdf.

3. The Joint United Nations Programme on HIV/AIDS (UNAIDS) (2023, September 01). Global HIV & AIDS Statistics—Fact Sheet. Available online: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.

4. European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2023, September 01). HIV/AIDS Surveillance in Europe 2022 (2021 Data). Available online: https://www.ecdc.europa.eu/sites/default/files/documents/2022-Annual_HIV_Report_final.pdf.

5. Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L.;Yamaguchi;J. Acquir. Immune Defic. Syndr.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3